Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fezolinetant Long-term Safety in Postmenopausal VMS (China, Phase 3)
CTR20200676Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fezolinetant in menopause, sponsored by Astellas Pharma. Started Apr 2020; status: completed.
02
Drugs
fezolinetant
03
Conditions
menopause
Beyond the preview
Go deeper on CTR20200676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200676.